J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 11,459 shares at $16.02 ($184K) on 2019-04-18, disclosed to the SEC on 2019-04-19.
Open-market sale of $184k FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 6,843 | $110K | 59.7% |
| 2 | $16.02 | 4,616 | $74K | 40.3% |
| Total | $16.01 avg | 11,459 | $184K | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |